Joint research & assay development
Combine your target biology and recognition chemistry with the EFIRM instrument, consumables and software platform.
FOR COLLABORATORS
EFIRM assay development
and research collaboration.
Build on EZLife Bio’s upstream EFIRM (Electric Field-Induced Release and Measurement) platform: EFIRM96 instrumentation, EPLATE consumables and software. Collaborate on research, assay kit development and independent validation. Universities, research institutes and strategic partners worldwide are welcome. For assay-development guidance, we prioritize collaboration; paid support may also be arranged per project.
SHARED QUESTIONS. RIGOROUS STUDIES.
Bring your expertise.
Build the evidence.
Independent evaluation
Discuss reproducibility, matrix effects, benchmark methods and multicenter study design.
Translational partnerships
Plan analytical validation and clinical research with appropriate ethics, governance and regulatory review.
Agree on the project scope, data access, publication and intellectual property terms before work starts.
FROM PLATFORM TO ASSAY
Your biology.
A defined development path.
EFIRM96, EPLATE and software provide a platform on which customers can research targets and develop their own assay kits.
- 01
Define the question
Select the analyte or sequence, specimen matrix, intended research use and appropriate comparator.
- 02
Design the recognition chemistry
Develop capture and detector probes or other target-specific reagents, and define the electrode and control layout.
- 03
Evaluate the complete assay
Assess precision, detection limits, interference and matrix effects using suitable reference materials and controls.
- 04
Transfer the workflow
Document the protocol, instrument settings and data interpretation, then assess reproducibility in the receiving laboratory.
Instrument purchase includes local software, training and general support. Method-development scope is agreed per project. A research plan should define EZLife’s support, the developer’s protocol and reagent work, and the receiving laboratory’s independent evaluation responsibilities. Diagnostic use requires validation for its intended use and an appropriate pathway.
RESEARCH FOUNDATION
Find evidence for your target.
Selected epidermal growth factor receptor (EGFR) variants provide one example of EFIRM research in plasma and saliva. Other applications require their own recognition chemistry, controls and validation.
Published detection without polymerase chain reaction (PCR) uses enzyme-mediated signal generation. Study results describe the target, sample type and experimental setup in each paper; research prototypes do not establish EFIRM96 product specifications.
COMPLEMENTARY EXPERTISE
A platform needs
an ecosystem.
EZLife Bio contributes instrumentation, electrode consumables and software. Partners bring the biology, evidence and application expertise that make a new assay useful.
Universities & research institutes
Bring new biomarker questions, recognition chemistry and independent experimental evaluation. Define shared study goals and publication plans.
Laboratories & assay developers
Bring specimen expertise, comparator methods and validation capabilities. Develop target-specific reagents and reproducible laboratory workflows.
Strategic & translation partners
Explore assay manufacturing, quality systems, application-specific regulatory pathways or regional distribution, with project responsibilities agreed together.
Projects begin with a defined target, specimen and intended use, then a shared plan for feasibility, validation and next steps. For CLIA-oriented translation, discuss intended use, reference methods, analytical validation and transfer to a receiving laboratory. Laboratory certification does not confer product approval. Project responsibilities and rights in jointly developed results are agreed by contract.
THE NEXT RESEARCH HORIZON
Molecular information.
Across time.
Our research thesis: reliable longitudinal molecular data is a critical missing layer for future AI-enabled health research.
Establish useful measurements
EFIRM96, EPLATE and software provide a laboratory platform for research and assay development. An automated prototype is available for demonstration and discussion with investment organizations and CLIA laboratories. It is a prototype, not a commercially available or clinically validated product.
Explore accessible sampling
Electrical control and current readout offer a route to miniaturization. Our longer-term goals include handheld instruments and smartphone modules, paired with appropriately validated assays.
Connect biology over time
Repeated saliva sampling could support molecular observations across time and physiological states. Carefully designed cohorts and reproducible measurements could create a data layer for future model-based research.
The path requires hardware development, assay validation, longitudinal studies and responsible data analysis. Handheld and smartphone products, continuous monitoring and AI-based clinical interpretation are future research goals.
Help develop the next research platformAPPLICATIONS ACROSS BIOLOGY
From human biomarkers to food identity.
Explore published EGFR, exosome, antibody, meat-species and soybean research, alongside genetic-variant and protein-assay development.
Explore research applications →ACADEMIC & BIOPHARMA COLLABORATION
From biomarker question
to an evaluation plan.
Start with your priorities. Discuss the scientific fit, practical requirements and next steps with our team.
Frame the scientific question
Define the target biology and the value of measuring it.
- Bring
- Non-confidential hypothesis, analyte / sequence, matrix and study stage.
- Discuss
- Scientific fit, prior evidence and key feasibility uncertainties.
Agree feasibility criteria
Define what a useful assay would need to demonstrate.
- Bring
- Comparator, representative materials and proposed acceptance criteria.
- Discuss
- Probe/reagent design, controls, interference and project responsibilities.
Evaluate against the plan
Design an evaluation that can test reproducibility and matrix effects.
- Bring
- Available expertise, equipment and material access; no patient identifiers.
- Discuss
- Study design, data analysis, governance, publication and intellectual property terms before work starts.
Discuss transfer & validation
Assess what further work a receiving laboratory or study would require.
- Bring
- Intended receiving setting and analytical or translational objectives.
- Discuss
- Protocol transfer, independent validation, documentation and appropriate ethics/regulatory review.
Start with non-confidential information. Do not send patient data, personal test results or confidential sequences through the website form. Confidentiality, material/data access and intellectual property terms must be agreed separately.
Email the EZLife Bio teamBuild the next study together.
Discuss a joint study, independent evaluation or research partnership.